Global Veterinary Drugs for Companion Animals Market Growth (Status and Outlook) 2025-2031

The global Veterinary Drugs for Companion Animals market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Veterinary drugs for companion animals refer to pharmaceutical products that are specifically designed and formulated for use in the treatment, prevention, or management of diseases, conditions, or health issues in pets or companion animals. These drugs are developed to address the unique physiological and medical needs of animals kept as companions, including dogs, cats, birds, rabbits, and other small animals.

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 22%.

LPI (LP Information)' newest research report, the “Veterinary Drugs for Companion Animals Industry Forecast” looks at past sales and reviews total world Veterinary Drugs for Companion Animals sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Drugs for Companion Animals sales for 2025 through 2031. With Veterinary Drugs for Companion Animals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Drugs for Companion Animals industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Drugs for Companion Animals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Drugs for Companion Animals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Drugs for Companion Animals market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Drugs for Companion Animals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Drugs for Companion Animals.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Drugs for Companion Animals market by product type, application, key players and key regions and countries.

Segmentation by Type:
Injection
Taking Class

Segmentation by Application:
Farm
Veterinary Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell

Please note: The report will take approximately 2 business days to prepare and deliver.